The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation

Arthritis and Rheumatism

Volumn 60, Issue 6, 2009, Pages 1661-1671

  Koziczak Holbro, Magdalena ^a   Littlewood Evans, Amanda ^a   Pöllinger, Bernadette ^a   Kovarik, Jiri ^a   Dawson, Janet ^a   Zenke, Gerhard ^a   Burkhart, Christoph ^a   Müller, Matthias ^a   Gram, Hermann ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTHRITIS; ARTICLE; BONE EROSION; CARTILAGE MATRIX; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; LYMPH NODE; MIXED LYMPHOCYTE CULTURE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE;

ANIMALS; ARTHRITIS; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCK-IN TECHNIQUES; IMMUNITY, INNATE; IMMUNOGLOBULIN G; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; NEUTROPHILS; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

EID: 66449130625     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24552     Document Type: Article

References (38)

1. Li S, Strelow A, Fontana EJ, Wesche H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A 2002;99:5567-5572 (Pubitemid 34411589)
2. Liu ZJ, Liu CA, Gong JP. IRAK-4: the key molecule of TLR/IL-1R common signal transduction system. Sheng Li Ke Xue Jin Zhan 2005;36:276-9. In Chinese.
3. Suzuki N, Suzuki S, Yeh WC. IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol 2002;23:503-506 (Pubitemid 35248046)
4. Kawagoe T, Sato S, Jung A, Yamamoto M, Matsui K, Kato H, et al. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J Exp Med 2007;204:1013-1024 (Pubitemid 46798146)
5. Kim TW, Staschke K, Bulek K, Yao J, Peters K, Oh KH, et al. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J Exp Med 2007;204:1025-1036 (Pubitemid 46798147)
6. Koziczak-Holbro M, Joyce C, Gluck A, Kinzel B, Muller M, Tschopp C, et al. IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and Toll-like receptor 7-mediated signaling and gene expression. J Biol Chem 2007;282:13552-13560 (Pubitemid 47100553)
7. Koziczak-Holbro M, Gluck A, Tschopp C, Mathison JC, Gram H. IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes. Eur J Immunol 2008;38:788-796
8. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006;6:823-835 (Pubitemid 44631651)
9. Van der Heijden IM, Wilbrink B, Tchetverikov I, Schrijver IA, Schouls LM, Hazenberg MP, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 2000;43:593-598 (Pubitemid 30394951)
10. Dawson J, Sedgwick AD, Edwards JC, Lees P. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int J Tissue React 1991;13:171-185
11. Grosios K, Wood J, Esser R, Raychaudhuri A, Dawson J. Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis. Inflamm Res 2004;53:133-142 (Pubitemid 38526596)
12. Yang YH, Morand EF, Getting SJ, Paul-Clark M, Liu DL, Yona S, et al. Modulation of inflammation and response to dexamethasone by annexin 1 in antigen-induced arthritis. Arthritis Rheum 2004;50:976-984 (Pubitemid 38326199)
13. Weckbecker G, Bruns C, Fischer KD, Heusser C, Li J, Metzler B, et al. Strongly reduced alloreactivity and long-term survival times of cardiac allografts in Vav1- and Vav1/Vav2-knockout mice. Transpl Int 2007;20:353-364 (Pubitemid 46310636)
14. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994;171:131-137 (Pubitemid 24140219)
15. Roark CL, French JD, Taylor MA, Bendele AM, Born WK, O'Brien RL. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing γδ T cells. J Immunol 2007;179:5576-5583
16. LaMontagne K, Littlewood-Evans A, Schnell C, O'Reilly T, Wyder L, Sanchez T, et al. Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization. Cancer Res 2006;66:221-231 (Pubitemid 43166028)
17. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996;87:811-822 (Pubitemid 26404281)
18. Ji H, Gauguier D, Ohmura K, Gonzalez A, Duchatelle V, Danoy P, et al. Genetic influences on the end-stage effector phase of arthritis. J Exp Med 2001;194:321-330 (Pubitemid 32730806)
19. Brackertz D, Mitchell GF, Mackay IR. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 1977;20:841-850
20. Pohlers D, Nissler K, Frey O, Simon J, Petrow PK, Kinne RW, et al. Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation. Clin Exp Immunol 2004;135:409-415 (Pubitemid 38297140)
21. Brackertz D, Mitchell GF, Vadas MA, Mackay IR. Studies on antigen-induced arthritis in mice. III. Cell and serum transfer experiments. J Immunol 1977;118:1645-1648 (Pubitemid 8097462)
22. Suzuki N, Suzuki S, Millar DG, Unno M, Hara H, Calzascia T, et al. A critical role for the innate immune signaling molecule IRAK-4 in T cell activation. Science 2006;311:1927-1932
23. Braley-Mullen H. Antigen requirements for induction of B-memory cells: studies with dinitrophenyl coupled to T-dependent and T-independent carriers. J Exp Med 1978;147:1824-1831 (Pubitemid 8372971)
24. Walsh DA, Pearson CI. Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res 2001;3:147-153 (Pubitemid 32303431)
25. Buma P, Groenenberg M, Rijken PF, van den Berg WB, Joosten L, Peters H. Quantitation of the changes in vascularity during arthritis in the knee joint of a mouse with a digital image analysis system. Anat Rec 2001;262:420-428 (Pubitemid 32250966)
26. Coxon A, Bolon B, Estrada J, Kaufman S, Scully S, Rattan A, et al. Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Arthritis Rheum 2002;46:2604-2612 (Pubitemid 36118923)
27. Joosten LA, Koenders MI, Smeets RL, Heuvelmans-Jacobs M, Helsen MM, Takeda K, et al. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J Immunol 2003;171:6145-6153 (Pubitemid 37467237)
28. Lee EK, Kang SM, Paik DJ, Kim JM, Youn J. Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. Int Immunol 2005;17:325-333 (Pubitemid 40372655)
29. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, Wunderink LU, et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006;176:7021-7027 (Pubitemid 43787883)
30. Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, et al. Critical roles for interleukin 1 and tumor necrosis factor in antibody-induced arthritis. J Exp Med 2002;196:77-85. (Pubitemid 34747313)
31. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, et al. Arthritis critically dependent on innate immune system players. Immunity 2002;16:157-168 (Pubitemid 34211957)
32. Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S, et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 2007;117:3786-3799 (Pubitemid 350224089)
33. Van den Berg WB. Joint inflammation and cartilage destruction may occur uncoupled. Springer Semin Immunopathol 1998;20:149-164 (Pubitemid 28502454)
34. Van Lent PL, Nabbe K, Blom AB, Holthuysen AE, Sloetjes A, van de Putte LB, et al. Role of activatory FcγRI and FcγRIII and inhibitory FcγRII in inflammation and cartilage destruction during experimental antigen-induced arthritis. Am J Pathol 2001;159:2309-2320 (Pubitemid 33104284)
35. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002;416:750-756 (Pubitemid 34429152)
36. Lye E, Dhanji S, Calzascia T, Elford AR, Ohashi PS. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses. Eur J Immunol 2008;38:870-876
37. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001;2:947-950 (Pubitemid 32976167)
38. Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007;204:2407-2422 (Pubitemid 47529326)